Author

Teagan Polotaye

Stevens Institute of TechnologyORCID 0009-0006-3566-4570Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Marcin IwanickiiD· 2 shared Cezary MiedziarekiD· 1 shared Daniel Centeno· 1 shared Daniel CentenoiD· 1 shared Elżbieta Dziabaszewska· 1 shared Jan Savas-Carstens· 1 shared Laura A. MartiniD· 1 shared Mikołaj Piotr ZaborowskiiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Marcin IwanickiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancersPeer-reviewedApr 27, 2025

Suppression of Ovarian Cancer Cell Proliferation is Associated with Upregulation of Cell-Matrix Adhesion Programs and Integrin-β4-Induced Cell Protection from Cisplatin.

Sadaf Farsinejad, Daniel Centeno, Jan Savas-Carstens…·Marcin Iwanicki

This study shows that integrin-β4 upregulation suppresses ovarian cancer cell proliferation and protects cells from cisplatin, suggesting a role in chemoresistance.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Student ResearchPeer-reviewedAug 31, 2024

Mutant p53R175H-Associated Protection of Ovarian Cancer Precursor Cells from Cisplatin Requires Expression of SLC6A6 Taurine Transporter

Teagan Polotaye, Daniel Centeno, Marcin Iwanicki

The paper shows that mutant p53R175H in ovarian cancer precursor cells protects them from cisplatin by requiring SLC6A6 taurine transporter expression.

1 citation

humanproteomics

𝕏 PostBluesky